A Randomized Controlled Dose-Escalation Study of LY06006, a Recombinant Humanized Monoclonal Antibody to RANKL, in Chinese Healthy Adults
一项针对中国健康成年人的随机对照剂量递增研究,评估重组人源化抗RANKL单克隆抗体LY06006的疗效
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2022.893166
Niu, Suping; Chen, Min; Yan, Diqin; Liu, Xiangxing; Guo, Shuren; Ou, Lun; Fan, Huaying; Lv, Jie; Wang, Qian; Dong, Wenliang; Xia, Lin; Wang, Simin; Liu, Gang; Gu, Qun; Guo, Danjie; Liu, Hongxia; Rao, Huiying; Zheng, Qingshan; Nie, Xiaoyan; Song, Haifeng; Fang, Yi